| Product Name | MF | CAS | Details |
|---|
| 3-(5-bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione | C13H11BrN2O3 | 1010100-26-1 | Details |
| Ziprasidone QT | C21H19ClN4O2S | 884305-07-1 | Details |
| NUC-3373 | C29H29FN3O9P | 1332837-31-6 | Details |
| 3-(4-hydroxy-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione | C13H12N2O4 | 1061604-41-8 | Details |
| 7-BROMO-8-METHYL-2,3-DIHYDRO-1H-PYRIDO[2,3-B][1,4]OXAZINE | C8H9BrN2O | 2169906-55-0 | Details |
| N-Benzyl-6-(4-phenylbutoxy)hexan-1-amine | C23H33NO | 97664-55-6 | Details |
| 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-fluoro-6-(1-piperazinyl)- | C17H17FN4O4 | 2222114-22-7 | Details |
| Olaparib dimer Impurity | C36H28F2N6O4 | 2250242-62-5 | Details |
| Fluticasone furoate EP impurity E | C25H31F3O5S | 398454-97-2 | Details |
| Fluticasone Acetate | C24H29F3O5S | 80474-24-4 | Details |
| 4,4,5,5,5-Pentafluoro-1-pentanol | C5H7F5O | 148043-73-6 | Details |
| Fluticasone EP IMpurity B | C24H30F2O6S | 948566-12-9 | Details |
| Fluticasone EP Impurity G | C43H51F5O8S | 220589-37-7 | Details |
| luticasone Impurity 18 | C26H28F2O7S | 948566-11-8 | Details |
| Regadenoson Impurity B | B | 7440-42-8 | Details |
| Regadenoson Impurity E | C13H15N7O4 | 1627202-38-3 | Details |
| GLP26 | C19H17F2N3O3 | 2133017-36-2 | Details |
| CC-90009 | C22H18ClF2N3O4 | 1860875-51-9 | Details |
| (R)-4-Amino-3-fluoro-2-methyl-2-butanol | C5H12FNO | 1544241-64-6 | Details |
| Acelarin | C25H27F2N4O8P | 840506-29-8 | Details |
| 11-ent-Mifepristone | C29H35NO2 | Details |
| (2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4,4-difluoro-2-(hydroxymethyl)tetrahydrofuran-3-yl tert-butyl carbonate | C14H19F2N3O6 | 250698-51-2 | Details |
| Sildenafil Impurity F | C27H32N6O4S | 1007310-62-4 | Details |
| Mometasone Furoate EP Impurity X | Details |
| tert-butyl 4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperazine-1-carboxylate | C22H26N4O6 | 2222114-64-7 | Details |
| 17-epi Mifepristone | Details |
| Mometasone Furoate EP Impurity U | Details |
| LY2334737 | C17H25F2N3O5 | 892128-60-8 | Details |
| Mometasone Furoate EP Impurity M | C22H29ClO4 | 57780-86-6 | Details |
| (R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride | C5H13ClFNO | 2242580-23-6 | Details |
| Mometasone Furoate EP Impurity A | C27H29ClO5 | 83880-65-3 | Details |
| Mometasone Furoate EP Impurity F | C27H28Cl2O7 | 1305334-30-8 | Details |
| Mometasone Furoate EP Impurity G | C22H28Cl2O4 | 105102-22-5 | Details |
| Regadenoson Impurity C | C15H17N7O6 | 1423073-21-5 | Details |
| Mometasone Furoate EP Impurity T | C27H30Cl2O6 | 83919-23-7 | Details |
| Fulvestrant EP Impurity B | C32H47F5O4S | 98008-06-1 | Details |
| Indacaterol dimmer Impurity | C49H49N3O6 | 1207760-24-4 | Details |
| Mometasone Furoate EP Impurity K | C22H29ClO5 | 4647-20-5 | Details |
| Regadenoson Impurity A | C14H15N7O6 | 313348-29-7 | Details |
| Chlorpheniramine impurity D | C17H18ClN3 | 65676-21-3 | Details |
| 17-ent-Mifepristone | Details |
| Mometasone Furoate EP Impurity D | C27H29ClO6 | 83881-09-8 | Details |
| 3-(5-(aminomethyl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione hydrochloride | C14H16ClN3O3 | 1158264-69-7 | Details |
| Mometasone Furoate EP Impurity Q | C22H27ClO4 | 83881-08-7 | Details |
| N-Demethyl Mifepristone | C28H33NO2 | 104004-96-8 | Details |
| NAGA/ N-acryloyl glycinamide | C5H8N2O2 | 2479-62-1 | Details |
| Indacaterol isomer Impurity | C31H34N2O3 | 773895-24-2 | Details |
| Chlorpheniramine impurity C | C19H21ClN2O4 | 22630-25-7 | Details |
| Mometasone Furoate EP Impurity C | C27H29ClO6 | 1305334-31-9 | Details |
| Salmeterol Impurity B | C23H33NO4 | 94749-02-7 | Details |
| Chlorpheniramine impurity E | C16H19ClN2O | 120244-82-8 | Details |
| Mometasone Furoate EP Impurity R | C28H33ClO9S | 1370190-08-1 | Details |
| Mometasone Furoate EP Impurity H | C27H31ClO7 | 148596-90-1 | Details |
| 6-keto Fulvestrant | C32H45F5O3S | 2170200-14-1 | Details |
| Fulvestrant EP Impurity C | C6H12O | 10141-72-7 | Details |
| Salmeterol Impurity A | C19H25NO3 | 1798014-51-3 | Details |
| 3-(6-fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione | C13H11FN2O3 | 2468780-87-0 | Details |
| Salmeterol Impurity F | C25H37NO4 | 1391052-40-2 | Details |
| Mometasone Furoate EP Impurity E | C32H32Cl2O8 | 1370190-33-2 | Details |
| Salmeterol Impurity C | C24H35NO4 | 94749-11-8 | Details |
| Mometasone Furoate EP Impurity S | C27H30Cl2O6 | 2231764-75-1 | Details |
| Brompheniramine impurity | C15H17BrN2 | 18453-10-6 | Details |
| Nelarabine | C11H15N5O5 | 121032-29-9 | Details |
| Clozolidine dechlorination impurity | C21H23ClFN5O | 1801651-84-2 | Details |
| 3-(4-(5-aminopent-1-yn-1-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione hydrochloride | C18H20ClN3O3 | 2489242-23-9 | Details |
| (1R,3S)-Methyl 3-aMinocyclopentanecarboxylate hydrochloride | C7H14ClNO2 | 180196-56-9 | Details |
| Vortioxetine Impurity 1 | C28H34N4S | 1240670-85-2 | Details |
| tert-butyl (5-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)pentyl)carbamate | C23H31N3O5 | 2138441-25-3 | Details |
| 3-(1-oxo-5-(piperidin-4-yl)isoindolin-2-yl)piperidine-2,6-dione | C18H21N3O3 | 2222115-40-2 | Details |
| methyl (1S,4R)-4-aminocyclopent-2-ene-1-carboxylate | C7H11NO2 | 138923-03-2 | Details |
| 2-(((tert-butoxycarbonyl)amino)methyl)thiazole-4-carboxylic acid | C10H14N2O4S | 71904-80-8 | Details |
| CC-885 | C22H21ClN4O4 | 1010100-07-8 | Details |
| Vamorolone | C22H28O4 | 13209-41-1 | Details |
| Fluticasone Furoate EP Impurity J | Details |
| 2,3,4-TRICHLOROBENZOIC ACID | C7H3Cl3O2 | 50-75-9 | Details |
| 1-(4-Nitrophenyl)-2-piperidinone | C11H12N2O3 | 38560-30-4 | Details |
| 6-Bromo-6-deoxy-gamma-cyclodextrin | C48H72Br8O32 | 53784-84-2 | Details |
| Mosapride chloride impurity | Details |
| ethyl 2-(aminomethyl)thiazole-4-carboxylate | C7H10N2O2S | 91711-96-5 | Details |
| CRBN | C20H16Cl2N2O4 | 1323404-53-0 | Details |
| 4-Chloroindoline | C8H8ClN | 41910-64-9 | Details |
| CRBN | C20H16Cl2N2O4 | 1061605-63-7 | Details |
| (7alpha,17beta)-17-(Acetyloxy)-7-(9-bromononyl)estr-4-en-3-one | C29H45BrO3 | 875573-63-0 | Details |
| CRBN | C20H16Cl2N2O4 | 1323404-55-2 | Details |
| (3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one | C26H26O5 | 55094-52-5 | Details |
| 5-oxo-5,6,7,8-tetrahydroquinoline-2-carbonitrile | C10H8N2O | 1471468-84-4 | Details |
| Catharanthine Sulfate | C21H26N2O6S | 70674-90-7 | Details |
| Saxagliptin | C18H25N3O2 | 361442-04-8 | Details |
| N1-(4-AMINO-2-CYANOPHENYL)ACETAMIDE | C9H9N3O | 73894-39-0 | Details |
| Mometasone Furoate EP Impurity O | C24H31ClO6 | 24916-91-4 | Details |
| 3-one-4-aza-5-androstene-17β-carboxylate methyl ester | C20H29NO3 | 104214-18-8 | Details |
| Afatinib impurity L | C22H20ClFN4O4 | 2223677-58-3 | Details |
| Apalutamide Impurity 2 | C21H15F4N5O3 | 1332391-92-0 | Details |
| 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindoline-5-carboxylic acid | C14H12N2O5 | 2171780-01-9 | Details |
| S-(4,4,5,5,5-Pentafluoropentyl)isothiourea Methanesulfonate | C7H13F5N2O3S2 | 1107606-68-7 | Details |
| Apalutamide Impurity | C20H17F4N5O2 | 1950587-20-8 | Details |
| Vindoline | C25H32N2O6 | 2182-14-1 | Details |
| Vortioxetine Impurity F | C38H44N4OS2 | 2476761-84-7 | Details |
| 5,5'-Dimethyldipyrromethane | C11H14N2 | 99840-54-7 | Details |
| Salmeterol impurity E | C25H37NO4 | 108928-81-0 | Details |
| 2-Keto Crizotinib | C21H20Cl2FN5O2 | 1415558-82-5 | Details |
| 1-(Aminomethyl)naphthalene hydrochloride | C11H12ClN | 39110-74-2 | Details |
| ethyl 5-oxo-5,6,7,8-tetrahydroquinoline-2-carboxylate | C12H13NO3 | 1616071-22-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||